Pre-hydrolysing pea protein before pepsin digestion dramatically increased the release of bioactive peptides that inhibit enzymes linked to diabetes and high blood pressure, with ACE inhibition reaching 95%.
95% ACE inhibitionAchieved by ultrafiltered peptides from pre-hydrolysed pea protein, suggesting strong blood pressure-lowering potential
What the researchers found
Pre-hydrolysed pea protein achieved a 64% degree of hydrolysis during pepsin digestion, compared to approximately 40% for non-hydrolysed samples. The resulting peptides showed stronger inhibition of key metabolic enzymes.
After ultrafiltration to concentrate small peptides (<10 kDa), the bioactive effects were dramatically enhanced:
- α-amylase inhibition: up to 44.5%
- α-glucosidase inhibition: up to 54%
- ACE inhibition: up to 95%
Peptidomic analysis identified unique peptide sequences in the pre-hydrolysed fractions, and computational modeling confirmed their bioactive potential.
Why it matters
Finding natural, food-derived peptides that can help regulate blood sugar and blood pressure is a growing area of nutritional science. This study shows that how plant proteins are processed significantly affects the bioactive potential of the peptides they release. The 95% ACE inhibition is particularly striking, suggesting pea-derived peptides could eventually be developed into functional foods or supplements for cardiovascular and metabolic health.
How the study worked
This was an in vitro laboratory study. Pea protein was either pre-hydrolysed with enzymes or left untreated, then subjected to simulated pepsin digestion. The resulting hydrolysates were filtered to concentrate small peptides (<10 kDa). Enzyme inhibition assays measured activity against α-amylase, α-glucosidase (both relevant to blood sugar), and ACE (relevant to blood pressure). Peptidomic analysis identified specific peptide sequences, and in silico prediction assessed their bioactive potential.
What this study cannot tell us
This is entirely an in vitro study — enzyme inhibition in a test tube does not guarantee the same effects will occur in the human body. Peptides may be further broken down during intestinal digestion, absorbed poorly, or metabolized before reaching their target enzymes. The in silico predictions of bioactivity need validation in cell and animal models. No human or animal studies were conducted to confirm real-world health effects.
How to read the evidence
This is a preclinical in vitro study demonstrating enzyme inhibition in laboratory conditions. While the results are promising and the methodology is sound, no animal or human studies were conducted. The evidence represents an early stage of investigation that requires significant further validation.
When this study was published
Published in 2025, this study represents current research in food-derived bioactive peptides and reflects the latest methods in peptidomics and functional food development.
The bigger picture
Plant-derived bioactive peptides represent a growing alternative to synthetic drugs for managing chronic metabolic conditions. Pea protein is particularly attractive because it is widely available, affordable, and allergen-friendly compared to dairy-based peptide sources. This work advances understanding of how processing methods can optimize bioactive peptide release, bringing the field closer to developing evidence-based functional food ingredients.
Questions still open
- Do these bioactive pea peptides survive full gastrointestinal digestion and retain their enzyme-inhibiting activity in the body?
- Could pre-hydrolysed pea protein be incorporated into everyday food products while maintaining its bioactive peptide profile?
- How do the blood pressure and blood sugar effects of these pea peptides compare to established pharmaceutical treatments in clinical settings?
Common questions
What does ACE inhibition mean for blood pressure?
Can I get these benefits by simply eating peas?
Read the original research
Enhanced Bioactive Peptide Release from Pre-Hydrolysed Pea Protein: Impact of Pepsin Digestion on Antidiabetic and Antihypertensive Functions.
Foods (Basel, Switzerland), 14(19)
Citation
Elbira, Arig; Hernández-Álvarez, Alan Javier; Boesch, Christine. (2025). Enhanced Bioactive Peptide Release from Pre-Hydrolysed Pea Protein: Impact of Pepsin Digestion on Antidiabetic and Antihypertensive Functions.. Foods (Basel, Switzerland), 14(19). https://doi.org/10.3390/foods14193306